BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21618255)

  • 1. Organ targeted prenatal gene therapy--how far are we?
    Mehta V; Abi Nader K; Waddington S; David AL
    Prenat Diagn; 2011 Jul; 31(7):720-34. PubMed ID: 21618255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sheep model of in utero gene therapy.
    Porada CD; Park P; Almeida-Porada G; Zanjani ED
    Fetal Diagn Ther; 2004; 19(1):23-30. PubMed ID: 14646413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candidate diseases for prenatal gene therapy.
    David AL; Waddington SN
    Methods Mol Biol; 2012; 891():9-39. PubMed ID: 22648766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for the fetus: is there a future?
    David AL; Peebles D
    Best Pract Res Clin Obstet Gynaecol; 2008 Feb; 22(1):203-18. PubMed ID: 17900991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal gene therapy: opportunities and risks.
    Wagner AM; Schoeberlein A; Surbek D
    Adv Drug Deliv Rev; 2009 Aug; 61(10):813-21. PubMed ID: 19426772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy progress and prospects: fetal gene therapy--first proofs of concept--some adverse effects.
    Coutelle C; Themis M; Waddington SN; Buckley SM; Gregory LG; Nivsarkar MS; David AL; Peebles D; Weisz B; Rodeck C
    Gene Ther; 2005 Nov; 12(22):1601-7. PubMed ID: 16136161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal muscle gene therapy/gene delivery in large animals.
    Abi-Nader KN; David AL
    Methods Mol Biol; 2011; 709():239-56. PubMed ID: 21194032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring for potential adverse effects of prenatal gene therapy: use of large animal models with relevance to human application.
    Mehta V; Abi-Nader KN; Carr D; Wallace J; Coutelle C; Waddington SN; Peebles D; David AL
    Methods Mol Biol; 2012; 891():291-328. PubMed ID: 22648778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal and neonatal gene therapy: benefits and pitfalls.
    Waddington SN; Kennea NL; Buckley SM; Gregory LG; Themis M; Coutelle C
    Gene Ther; 2004 Oct; 11 Suppl 1():S92-7. PubMed ID: 15454963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal gene transfer.
    Waddington SN; Buckley SM; David AL; Peebles DM; Rodeck CH; Coutelle C
    Curr Opin Mol Ther; 2007 Oct; 9(5):432-8. PubMed ID: 17932807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B.
    Schneider H; Adebakin S; Themis M; Cook T; Douar AM; Pavirani A; Coutelle C
    J Gene Med; 1999; 1(6):424-32. PubMed ID: 10753068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly efficient gene transfer into preterm CD34 hematopoietic progenitor cells.
    Shields LE; Kiem HP; Andrews RG
    Am J Obstet Gynecol; 2000 Sep; 183(3):732-7. PubMed ID: 10992201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentiviral vector-mediated, in vivo gene transfer to the tracheobronchial tree in fetal rabbits.
    Skarsgard ED; Huang L; Reebye SC; Yeung AY; Jia WW
    J Pediatr Surg; 2005 Dec; 40(12):1817-21. PubMed ID: 16338297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell and genetic therapies for the fetus.
    Roybal JL; Santore MT; Flake AW
    Semin Fetal Neonatal Med; 2010 Feb; 15(1):46-51. PubMed ID: 19540822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In utero gene therapy: current challenges and perspectives.
    Waddington SN; Kramer MG; Hernandez-Alcoceba R; Buckley SM; Themis M; Coutelle C; Prieto J
    Mol Ther; 2005 May; 11(5):661-76. PubMed ID: 15851005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term transgene expression by administration of a lentivirus-based vector to the fetal circulation of immuno-competent mice.
    Waddington SN; Mitrophanous KA; Ellard FM; Buckley SM; Nivsarkar M; Lawrence L; Cook HT; Al-Allaf F; Bigger B; Kingsman SM; Coutelle C; Themis M
    Gene Ther; 2003 Aug; 10(15):1234-40. PubMed ID: 12858188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary inflammation associated with repeated, prenatal exposure to an E1, E3-deleted adenoviral vector in sheep.
    Iwamoto HS; Trapnell BC; McConnell CJ; Daugherty C; Whitsett JA
    Gene Ther; 1999 Jan; 6(1):98-106. PubMed ID: 10341881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic gene therapy. Present situation and future perspective.
    Gottschalk U; Chan S
    Arzneimittelforschung; 1998 Nov; 48(11):1111-20. PubMed ID: 9850435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
    High KA
    Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and prospects: gene transfer into embryonic stem cells.
    Yates F; Daley GQ
    Gene Ther; 2006 Oct; 13(20):1431-9. PubMed ID: 17016468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.